At IQVIA, I led aggregate reporting and literature surveillance for regulatory safety deliverables, including PSUR, PBRER, and DSUR reports. My work included screening literature with DistillerSR, Embase, and Medline, and contributed to a 95% on-time submission rate.
Earlier at IQVIA, I led regional clinical operations and endpoint adjudication workflows for global Phase III trials, coordinating sites across Asia, Europe, and the United States. At Mahaveer Jain Hospital, I coordinated multicenter Phase III studies in Ophthalmology and Dermatology and supported source documentation review and inspection readiness.

